Search results

…Dr. Purser explores IL-23 and Th17 signaling in fatty liver disease and inflammatory liver conditions. Older terms NAFLD and NASH appear alongside the newer terms MASLD and MASH. Follow the pathway This teaching follows IL-23 receptor sign…

…tance, and inflammatory responses in the liver. Fatty liver disease can progress to inflammation and scarring in some people. Follow the pathway Dr. Purser discusses hepatic stellate cells, fibrosis, and the interaction of cytokines with r…

…r changes in red-cell turnover alongside true hypoglycemia. Kidney or liver conditions and certain medicines can also complicate interpretation. Bring these questions to your visit Ask whether glucose measurements agree with A1C and whethe…

…ity is being monitored and what benefits and risks apply to disease-modifying treatment. Antioxidant or nutrient discussions do not establish reversal of demyelination or replace the treatment plan.

… alleles do not alone prove a deficiency or mean that liver disease will occur.

… Purser follows the CCL2–CCR2 pathway through blood-vessel, kidney, and metabolic inflammation. He discusses homocysteine, NF-κB signaling, and reactive oxygen species as interacting parts of this picture, alongside glutathione, superoxide …

…have several explanations and does not establish a specific disease. Bring these questions to your visit Ask which result is being discussed: a genetic variant, a measured protein level, or a diagnosed condition. How does it fit with your …

…e questions to your visit Ask whether ADMA, blood pressure, kidney function, or another measured finding is relevant to your situation. A genetic entry alone cannot show how much nitric oxide your vessels are producing.

… discussing a result, and an association does not establish disease. Bring these questions to your visit Ask which result is being discussed: a genetic variant, a measured protein level, or a diagnosed condition. How does it fit with your …

…A promoter variant, alongside psoriasis, inflammatory joint disease, and inflammatory bowel disease. He explains how IL-23 can help sustain the Th17 response. A research association is different from a diagnosis or a reason to select a medi…

…it relevant to discussions of psoriasis, inflammatory bowel disease, and some inflammatory joint conditions. Bring these questions to your visit Ask which result is being discussed: a genetic variant, a measured protein level, or a diagnos…

…r connects IL-23 receptor signaling with inflammatory bowel disease, psoriasis, and inflammatory joint pathways. Targeting IL-23 with a medicine is different from concluding that a genetic result proves excessive receptor activity. Bring t…